A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lung Research Qld
Chermside, Queensland, Australia
- Flinders Medical Centre
Adelaide, South Australia, Australia
- Respiratory Clinical Trials
Kent Town, South Australia, Australia
- Institute for Respiratory Health Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Trialswest
Spearwood, Western Australia, Australia
- Cliniques Universitaires St-Luc
Louvain-la-Neuve, Wallon Region, Belgium
- Uz Antwerp
Antwerp, Belgium
- Cub Hopital Erasme
Brussels, Belgium
- Uz Leuven- Campus Gasthuisberg
Brussels, Belgium
- Chu Ucl Namur Site Godinne
Namur, Belgium
- Firestone Institute for Respiratory Health
Hamilton, Ontario, Canada
- Dr Anees Medicine Professional Corporation
Windsor, Ontario, Canada
- Dr Dhar Medical Practice
Windsor, Ontario, Canada
- Toronto General Hosp Research Inst
Toronto, Canada
- Groupe Hospitalier Hopitaux Universitaires Paris-Seine-Saint-Denis-Hopital Avicenne
Bobigny, France
- Chru Lille - Hopital Calmette
Lille, France
- Hopital Nord de Marseille
Marseille, France
- Aphp - Hopital Europen Georges-Pompidou
Paris, France
- Hopital Bichat
Paris, France
- Centre Hospitalier Universitaire de Rennes Hopital Pontchaillou
Rennes, France
- Chu de la Réunion Site Sud (terre Sainte)
Saint-Pierre, France
- Chu de la Réunion- Site Félix Guyon
Saint-Pierre, France
- Hopitaux Universitaires de Strasborg Service de Pneumologie Nouvel Hopital Civil
Strasbourg, France
- Centre Hospitalier Rgional Et Universitaire - Hopital Bretonneau
Tours, France
- Chapidze Emergency Cardiology Center
Tbilisi, Georgia
- the First Medical Center
Tbilisi, Georgia
- Thoraxklinik-Heidelberg Ggmbh
Heidelberg, Baden-Wurttemberg, Germany
- Lungenfachklinik Immenhausen Department for Clinical Studies
Immenhausen, Hesse, Germany
- Zms Zentrum Für Medizinische Studien Gmbh
Warendorf, Rhine-Westphalia, Germany
- Klifeck Gmbh Praxis Med. Gerald Eckhardt
Delitzsch, Saxony, Germany
- Studienzentrum Dr.Med Falk Brunner Fa Fuer Innere Medizin Und Pneumologie
Leipzig, Saxony, Germany
- Cims Studienzentrum Bamberg Gmbh
Bamberg, Germany
- Krankenhaus Donaustauf
Donaustauf, Germany
- Ruhrlandklinik Essen
Essen, Germany
- Pois Leipzig Gbr
Leipzig, Germany
- Universitaetsklinikum Leipzig Klinik Und Poliklinik Für Onkologie, Gastroenterologie, Hepatologie, P
Leipzig, Germany
- Klinikum Grossadern Der Ludwig-Maximilians-Universitaet Muenchen
Munich, Germany
- Trinity Centre for Health Sciences
Dublin, Ireland
- Hadassah Medical Center
Jerusalem, Israel
- Meir Medical Center
Kefar Sava, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Feb 2019
- Primary completion
- 17 May 2023
- Completion
- 17 May 2023
- Last update posted
- 22 May 2024
- Registered enrollment
- 172
- Registry id
- NCT03832946
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.